04 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/04/3093580/0/en/60-Degrees-Pharmaceuticals-Expands-Options-for-Malaria-Prevention-with-Introduction-of-ARAKODA-tafenoquine-8-Count-Bottle-Format.html
08 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/08/3057618/0/en/Sixty-Degrees-Pharmaceuticals-Announces-Patent-License-Agreement-to-Advance-Development-of-Tafenoquine-for-Babesiosis-Treatment-and-Prevention-with-Yale-School-of-Medicine-and-Yale.html
11 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/11/3024516/0/en/Sixty-Degrees-Pharmaceuticals-to-Ensure-Continuity-of-Tafenoquine-Supply-in-U-S-by-Importing-Limited-Quantity-of-KODATEF.html
28 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/28/3016354/0/en/60-Degrees-Pharma-Announces-IRB-Approval-of-Phase-II-Study-to-Evaluate-Tafenoquine-for-Chronic-Babesiosis.html
08 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/08/3006241/0/en/60-Degrees-Pharmaceuticals-Enrolls-First-Patient-in-Tafenoquine-Expanded-Access-Clinical-Study-for-Persistent-B-microti-Babesiosis.html
11 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/11/2995432/0/en/60-Degrees-Pharmaceuticals-Expands-Tafenoquine-Clinical-Trial-for-Babesiosis-to-Brigham-and-Women-s-Hospital.html